News
TKPHF
35.00
NaN%
--
Analysts’ Top Healthcare Picks: Takeda Pharmaceutical Co (TKPHF), Omada Health, Inc. (OMDA)
TipRanks · 2d ago
Takeda upgraded to Outperform from Market Perform at Bernstein
TipRanks · 2d ago
Weekly Report: what happened at TKPHF last week (0330-0403)?
Weekly Report · 4d ago
Denali Therapeutics regains full rights to DNL593
TipRanks · 4d ago
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)
TipRanks · 5d ago
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
NASDAQ · 04/03 09:10
Abivax appoints Michael Nesrallah as chief commercial officer
TipRanks · 04/01 20:21
Axsome Inks Agreement To Obtain Exclusive Global Rights To TAK-063 From Takeda
NASDAQ · 04/01 11:44
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
TipRanks · 04/01 11:22
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
TipRanks · 03/30 15:50
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade)
Seeking Alpha · 03/30 13:17
Alumis price target raised to $55 from $50 at Oppenheimer
TipRanks · 03/30 11:51
Weekly Report: what happened at TKPHF last week (0323-0327)?
Weekly Report · 03/30 10:08
Takeda’s Oral Psoriasis Drug Zasocitinib Shows Strong Phase 3 Results
TipRanks · 03/29 23:52
Takeda's Zasocitinib Shows Rapid, Durable Skin Clearance In Phase 3 Psoriasis Trials
NASDAQ · 03/29 15:11
Takeda announces new data from Phase 3 studies of TAK-279
TipRanks · 03/29 14:55
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
TipRanks · 03/26 07:00
Takeda: 'Hold' Despite Performance In 2025-2026
Seeking Alpha · 03/25 21:24
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
TipRanks · 03/25 08:53
Alkermes price target lowered to $43 from $45 at Piper Sandler
TipRanks · 03/24 10:42
More
Webull provides a variety of real-time TKPHF stock news. You can receive the latest news about Takeda Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TKPHF
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.